CTVA Financial Statements & Analysis
Complete financial statements for CTVA including income statement, balance sheet, and cash flow statement. Analyze CTVA's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
60
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
-1.8% ↓
Net Income
23.4% ↑
Gross Margin
2.9% ↑
Operating Margin
1.2% ↑
Balance Sheet
Current Ratio
-6.9% ↓
Debt to Equity
14.3% ↓
Asset Turnover
3.4% ↑
Cash Flow
Operating Cash Flow
21.3% ↑
Net Cash Flow
157.4% ↑
Free Cash Flow
31.9% ↑
Cash Flow to Debt
11.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 17.23B | 16.91B | 1.8% | |
| Gross Profit | 7.31B | 7.38B | 1.0% | |
| Operating Income | 2.11B | 2.10B | 0.7% | |
| Net Income | 735.00M | 907.00M | 23.4% | |
| EPS | 1.04 | 1.31 | 26.0% | |
| EBITDA | 2.54B | 2.73B | 7.8% | |
| Gross Margin | 42.41% | 43.64% | 2.9% | |
| Operating Margin | 12.25% | 12.40% | 1.2% | |
| Net Income Margin | 4.27% | 5.36% | 25.7% | |
| R&D Expenses | 1.34B | 1.40B | 4.9% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 16.91B | 17.23B | 17.45B | 15.65B | 14.22B |
| Gross Profit | 7.38B | 7.31B | 7.02B | 6.43B | 5.71B |
| Operating Income | 2.10B | 2.11B | 1.93B | 1.32B | 843.00M |
| Net Income | 907.00M | 735.00M | 1.15B | 1.76B | 681.00M |
| EPS | 1.31 | 1.04 | 1.59 | 2.39 | 0.91 |
| EBITDA | 2.73B | 2.54B | 2.73B | 3.62B | 1.90B |
| Gross Margin | 43.64% | 42.41% | 40.21% | 41.11% | 40.16% |
| Operating Margin | 12.40% | 12.25% | 11.05% | 8.41% | 5.93% |
| Net Income Margin | 5.36% | 4.27% | 6.57% | 11.24% | 4.79% |
| R&D Expenses | 1.40B | 1.34B | 1.22B | 1.19B | 1.14B |